139 related articles for article (PubMed ID: 35685424)
1. Plasma cfDNA for the Diagnosis and Prognosis of Colorectal Cancer.
Wu Z; Yu L; Hou J; Cui L; Huang Y; Chen Q; Sun Y; Lu W; Zhang C; Sun D
J Oncol; 2022; 2022():9538384. PubMed ID: 35685424
[TBL] [Abstract][Full Text] [Related]
2. Serum cell-free DNA concentrations and integrity analysis of colorectal cancer patients before and after surgery.
Cao G; Xie Y; Jiang X; Tian X; Wang D; Sun Y
Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):44-51. PubMed ID: 31472046
[TBL] [Abstract][Full Text] [Related]
3. Cell-free DNA as a biomarker for colorectal cancer: a retrospective analysis in patients before and after surgery.
Zhong Y; Zhou Q; Zhang Y; Zhou S; Zhang G; Jiang C; Zhang Z; Zhang X; Xu J; Jin C; Cao L; Chen L
Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):135-141. PubMed ID: 32415940
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic value of plasma cell-free DNA combined with VEGF-C in laryngeal squamous cell carcinoma.
Huang Q; Ji M; Li F; Li Y; Zhou X; Hsueh CY; Zhou L
Mol Cell Probes; 2023 Feb; 67():101895. PubMed ID: 36682577
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of plasma cfDNA concentration and integrity in breast cancer patients.
Miao Y; Fan Y; Zhang L; Ma T; Li R
Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):64-72. PubMed ID: 31472049
[TBL] [Abstract][Full Text] [Related]
6. The analysis of cell-free DNA concentrations and integrity in serum of initial and treated of lymphoma patients.
Wu J; Tang W; Huang L; Hou N; Wu J; Cheng X; Ma D; Qian P; Shen Q; Guo W; Peng W; Liu Y; Jiang C; Feng J
Clin Biochem; 2019 Jan; 63():59-65. PubMed ID: 30292543
[TBL] [Abstract][Full Text] [Related]
7. Different primers for diagnosing circulating cell-free DNA of colorectal cancer.
Shi H; Li Q; Liao J; Bai L; Wu S; Xie J; He G
Transl Cancer Res; 2020 May; 9(5):3435-3442. PubMed ID: 35117709
[TBL] [Abstract][Full Text] [Related]
8. Combinations of plasma cfDNA concentration, integrity and tumor markers are promising biomarkers for early diagnosis of non-small cell lung cancer.
Ren S; Zeng G; Yi Y; Liu L; Tu H; Chai T; Hu L
Heliyon; 2023 Oct; 9(10):e20851. PubMed ID: 37860559
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of cell-free DNA concentration and integrity in serum of gastric cancer patients before and after surgery.
Zhang X; Wu Z; Shen Q; Li R; Jiang X; Wu J; Li D; Wang D; Zou C; Zhong Y; Cheng X
Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):111-117. PubMed ID: 31880527
[TBL] [Abstract][Full Text] [Related]
10. Analysis of serum cfDNA concentration and integrity before and after surgery in patients with lung cancer.
Fan Y; Shi M; Chen S; Ju G; Chen L; Lu H; Chen J; Zheng S
Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):56-63. PubMed ID: 31472048
[TBL] [Abstract][Full Text] [Related]
11. Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis.
Leng S; Zheng J; Jin Y; Zhang H; Zhu Y; Wu J; Xu Y; Zhang P
Clin Chim Acta; 2018 Feb; 477():160-165. PubMed ID: 29113814
[TBL] [Abstract][Full Text] [Related]
12. Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden.
Bhangu JS; Taghizadeh H; Braunschmid T; Bachleitner-Hofmann T; Mannhalter C
Surg Oncol; 2017 Dec; 26(4):395-401. PubMed ID: 29113658
[TBL] [Abstract][Full Text] [Related]
13. Quantification of mitochondrial cfDNA reveals new perspectives for early diagnosis of colorectal cancer.
Linke C; Hunger R; Reinwald M; Deckert M; Mantke R
BMC Cancer; 2023 Mar; 23(1):291. PubMed ID: 36997875
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients.
Bedin C; Enzo MV; Del Bianco P; Pucciarelli S; Nitti D; Agostini M
Int J Cancer; 2017 Apr; 140(8):1888-1898. PubMed ID: 27943272
[TBL] [Abstract][Full Text] [Related]
15. Plasma cfDNA as a Potential Biomarker to Evaluate the Efficacy of Chemotherapy in Gastric Cancer.
Zhong Y; Fan Q; Zhou Z; Wang Y; He K; Lu J
Cancer Manag Res; 2020; 12():3099-3106. PubMed ID: 32440208
[TBL] [Abstract][Full Text] [Related]
16. Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
Spindler KG; Boysen AK; Pallisgård N; Johansen JS; Tabernero J; Sørensen MM; Jensen BV; Hansen TF; Sefrioui D; Andersen RF; Brandslund I; Jakobsen A
Oncologist; 2017 Sep; 22(9):1049-1055. PubMed ID: 28778958
[TBL] [Abstract][Full Text] [Related]
17. LINE-1 hypomethylation status of circulating cell-free DNA in plasma as a biomarker for colorectal cancer.
Nagai Y; Sunami E; Yamamoto Y; Hata K; Okada S; Murono K; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Kawai K; Nozawa H; Ishihara S; Hoon DS; Watanabe T
Oncotarget; 2017 Feb; 8(7):11906-11916. PubMed ID: 28060757
[TBL] [Abstract][Full Text] [Related]
18. [Quantitation of Circulating Cell-free DNA in Patients with Lymphoma and Its Clinical Significance].
Chen YY; Guo SQ; Li YH; Wang DM; Liu X; Zhang YX; Wang SY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1390-1396. PubMed ID: 27784363
[TBL] [Abstract][Full Text] [Related]
19. Investigation of Efficacy Evaluation Comparison of cfDNA and CEA in Colorectal Cancer.
Yu D; An G; Xu L
Clin Lab; 2016 Oct; 62(10):1947-1953. PubMed ID: 28164530
[TBL] [Abstract][Full Text] [Related]
20. [Value of the concentration and integrity of serum cell-free DNA for the clinical diagnosis of esophageal carcinoma].
Qiu YW; Shen XJ; Jin CJ; Cao XJ; Ju SQ
Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):905-910. PubMed ID: 30605980
[No Abstract] [Full Text] [Related]
[Next] [New Search]